According to research conducted by Jafarlou et al., the concurrent siRNA-mediated suppression of the Mcl-1 and Survivin genes in human monocytic leukemia cells significantly augments their chemosensitivity to chemotherapeutic agents (60). This evidence concerns the gene MCL1 and monocytic leukemia.